Description

DOXFORD-M is a combination tablet containing sustained-release Doxofylline 400 mg and Montelukast 10 mg, supplied in a blister pack. This combination is commonly prescribed for the long-term management and prevention of respiratory conditions involving bronchoconstriction and airway inflammation, such as asthma and chronic obstructive pulmonary disease (COPD).

How DOXFORD-M Works

Doxofylline: A bronchodilator that relaxes muscles in the airways, widens bronchial passages, and makes breathing easier by inhibiting airway smooth muscle contraction.
Montelukast: A leukotriene receptor antagonist that blocks leukotriene-mediated airway inflammation and swelling, decreasing the risk of asthma attacks and relieving allergy-triggered bronchospasm.

Uses of DOXFORD-M

Prevention and maintenance treatment of asthma
Management of COPD and other chronic bronchial diseases
Control and prophylaxis of allergy-related airway inflammation and exercise-induced bronchospasm.

Benefits

Offers combined bronchodilation and anti-inflammatory effects for better asthma and COPD control
Reduces airway swelling, wheezing, and shortness of breath
Decreases the frequency and severity of asthma attacks, especially in patients with both bronchospasm and allergy-driven symptoms.

Side Effects

Potential side effects may include:

Nausea, vomiting, diarrhea, headache, abdominal pain, heartburn
Drowsiness, dizziness, insomnia, or mild allergic reactions (rash, itching)
Rarely: changes in mood or liver enzymes, palpitations, or upper respiratory infections.

Precautions and Advice

Take DOXFORD-M as prescribed, ideally at the same time each day, preferably in the evening after food
Not for acute asthma relief—use emergency inhaler for sudden symptoms
Caution if history of liver disease, peptic ulcer, or psychiatric illness
Do not stop abruptly without consulting a healthcare provider.

DOXFORD-M is a prescription medication for ongoing respiratory disease management and should be used only under medical supervision.